{"nct_id":"NCT00298675","title":"Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors","status":"COMPLETED","status_verified_date":"2012-08","start_date":"2006-03","start_date_type":null,"primary_completion_date":"2010-07","primary_completion_date_type":"ACTUAL","completion_date":"2011-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["SNY"]}